Three months into COVID-19, and things are looking down (in a good way)

CMS has released their latest round of drug pricing data, giving us further insights into how the prescription drug supply chain is responding to the new challenges and demands presented by the COVID-19 pandemic. While many expected the pressures to cause massive shortages and price increases, the data shows that while shortages have definitely jumped, this new CMS drug pricing data shows that not only have generic drug prices stayed in check, but they actually appear to be deflating! But of course, the details matter, and we’ve got them for you.

Ben LinkJuly 28, 2020NADAC, Medicaid, Generic, COVID, Methylphenidate, Concerta, Ritalin, dexamethasone, Plaquenil, Hydroxychloroquine, ADHD, Zoloft, sertraline